Commentary: Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor Targeted to Endothelium Decreases Cell Activation is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R43EY028779-01A1
Development of first-in-class TREM-1 inhibitors for neovascular retinal diseases
National Institutes of Health
Grant: 1R43GM128369-01A1
Novel TREM-1 targeting therapies for sepsis
National Institutes of Health
Grant: 2R44CA217400-02
First-in-class TREM-1 inhibitors in combination therapy for pancreatic cancer
NCI NIH HHS
Grant: R43 CA217400
NEI NIH HHS
Grant: R43 EY028779
NIGMS NIH HHS
Grant: R43 GM128369
NCI NIH HHS
Grant: R44 CA217400
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals